Cetera Investment Advisers
TNYA icon

Cetera Investment Advisers’s Tenaya Therapeutics TNYA Stock Holding History

Cetera Investment Advisers’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48.4K Sell
69,875
-36,550
-34% -$27K ﹤0.01% 4584
2025
Q4 		$75.7K Buy
106,425
+55,000
+107% +$74.8K ﹤0.01% 4455
2025
Q3 		$83.3K Buy
+51,425
New +$51.8K ﹤0.01% 4360

Other funds holding TNYA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cetera Investment Advisers's TNYA Position: Q1 2026 in Review

Cetera Investment Advisers reduced its Tenaya Therapeutics (TNYA) stake by 34% in Q1 2026, selling an estimated $27K and leaving 69,875 shares worth $48.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4584.

Cetera Investment Advisers first reported a position in TNYA in Q3 2025 and has held it in 3 quarters since. The position peaked at $83.3K in Q3 2025. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • Cetera Investment Advisers held 69,875 shares of Tenaya Therapeutics worth $48.4K as of Q1 2026.
  • Cetera Investment Advisers sold 36,550 Tenaya Therapeutics shares in Q1 2026, an estimated $27K.
  • Tenaya Therapeutics made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #4584 holding.
  • Cetera Investment Advisers first reported a position in Tenaya Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Cetera Investment Advisers's Tenaya Therapeutics position peaked at $83.3K in Q3 2025.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.